Transuite Org (TRSO) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 28, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2026, filed Aug 13, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the TRSO SEC filings page.
Transuite Org Inc (TRSO) reported $118K in revenue for fiscal year 2025. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
The latest figures portray a liability-heavy business whose reported gross margin expanded while operations still consumed cash.
FY2023 net income of$14.8K coexisted with operating cash flow of-$114K , so reported profit did not translate into cash. The supplied-771.5% cash-to-profit ratio alongside$147K of financing cash flow shows that accounting earnings and funding mechanics were moving in opposite directions.
By FY2025, liabilities were
From FY2023 to FY2025, revenue increased
Financial Health Signals
We do not publish a peer-relative financial health score for Transuite Org Inc, because the score only covers companies whose filings and listing give us what it needs to compare them with their peers. The metrics below are current.
Key Financial Metrics
Earnings & Revenue
Transuite Org Inc generated $126K in revenue in Q2 2026. This represents an increase of 152.5% from the same quarter a year earlier. Against the prior quarter it is up 3.7%.
Transuite Org Inc earned -$0.06 per diluted share (EPS) in Q2 2026. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
Not reported for Q2 2026.
Not reported for Q2 2026.
Cash & Balance Sheet
Transuite Org Inc recorded an outflow of $39K in free cash flow in Q2 2026, representing a cash shortfall after capex. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
Transuite Org Inc held $107K in cash as of Q2 2026; no long-term debt figure is on record for that period.
Not reported for Q2 2026.
Margins & Returns
Transuite Org Inc's gross margin was 93.0% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is down 7.0 percentage points from the same quarter a year earlier. Against the prior quarter it is up 3.0 percentage points.
Not reported for Q2 2026.
Not reported for Q2 2026.
Not reported for Q2 2026.
Capital Allocation
Transuite Org Inc invested $50K in capex in Q2 2026, funding long-term assets and infrastructure. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. Against the prior quarter it is up 86.7%.
Not reported for Q2 2026.
Not reported for Q2 2026.
TRSO Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $126K+152.5% | $122Kn/m | N/A | $65Kn/m | $50Kn/m | $0 | N/A | $0-100.0% |
| Cost of Revenue | $9Kn/m | $12Kn/m | N/A | N/A | $0 | $0 | N/A | N/A |
| Gross Profit | $117K+134.8% | $110Kn/m | N/A | N/A | $50K | $0 | N/A | N/A |
| SG&A Expenses | $31K+3669.3% | $15K+14705.8% | N/A | $6Kn/m | $820n/m | $103n/m | $12K-12.6% | $0-100.0% |
| Operating Income | N/A | N/A | N/A | -$20.9Mn/m | N/A | -$483Kn/m | N/A | -$190K-4597.1% |
| EBITDA | N/A | N/A | N/A | -$20.9Mn/m | N/A | -$480Kn/m | N/A | -$187K |
| Interest Expense | $3K-35.8% | $47-98.5% | N/A | $4Kn/m | $4K+52.4% | $3K+130.9% | N/A | $0-100.0% |
| Income Tax | $0n/m | $0n/m | N/A | $0n/m | $0n/m | $0n/m | $0 | $0 |
| Net Income | N/A | N/A | N/A | -$20.9Mn/m | N/A | -$486Kn/m | N/A | -$190K-7164.7% |
| EPS (Basic) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -$0.01n/m |
| EPS (Diluted) | -$0.06 | -$0.05 | N/A | -$0.96 | -$0.58 | -$0.06 | -$0.02 | -$0.05 |
| Diluted Shares (Avg) | 74M | 69M | N/A | 22M | 11M | 8M | N/A | 4M |
Not reported in any period shown, so not listed: R&D Expenses.
TRSO Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $663K+81.8% | $496K+54.1% | $337K+371.1% | $37.4M+42189.0% | $365K+183.8% | $322K+110.7% | $72K-62.1% | $88K+92.7% |
| Current Assets | $575K+74.0% | $455K+59.6% | $320K+929.8% | $300K+590.0% | $331K+311.9% | $285K+180.8% | $31K-76.8% | $43K+301.8% |
| Cash & Equivalents | $107K+106893.0% | $5K+1086.7% | $4Kn/m | $14K+29.7% | $100-99.1% | $383-96.5% | $0-100.0% | $11K0.0% |
| Short-Term Investments | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m |
| Accounts Receivable | $30K-39.3% | $121K | $19Kn/m | $15K | $50K | N/A | $0 | N/A |
| Long-Term Investments | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m |
| Goodwill | N/A | N/A | N/A | $12.5M | N/A | N/A | $0 | N/A |
| Total Liabilities | $973K+234.8% | $386K+29.5% | $810K+116.7% | $23.2M+15002.5% | $291K+14.3% | $299K+27.1% | $374K+68.1% | $154K+96.0% |
| Current Liabilities | $878K+892.3% | $346K+234.9% | $810K+259.5% | $153K-0.4% | $88K-42.4% | $103K-32.8% | $225K+31.3% | $154K+96.0% |
| Non-Current Liabilities | $95K-53.0% | $41K-79.2% | $0-100.0% | $23.0Mn/m | $202K+100.8% | $195K+140.0% | $148K+193.0% | $0n/m |
| Total Equity | -$289K-540.9% | $155K+941.4% | -$485Kn/m | $14.2Mn/m | $65Kn/m | $15Kn/m | -$311Kn/m | -$65Kn/m |
| Retained Earnings | -$45.6Mn/m | -$40.8Mn/m | -$37.6Mn/m | -$28.4Mn/m | -$7.5Mn/m | -$945Kn/m | -$459Kn/m | -$215Kn/m |
Not reported in any period shown, so not listed: Inventory, Long-Term Debt.
TRSO Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $10Kn/m | -$5Kn/m | -$41Kn/m | $64Kn/m | -$20Kn/m | -$72Kn/m | -$57Kn/m | -$4K-161.6% |
| Depreciation & Amortization | $4K+24.2% | $2K-32.0% | N/A | $3K-4.7% | $3K0.0% | $3K0.0% | $3K+41.1% | $3K |
| Stock-Based Compensation | N/A | $3.3M+711.4% | N/A | N/A | N/A | $409Kn/m | N/A | N/A |
| Capital Expenditures | $50Kn/m | $27Kn/m | N/A | N/A | $0 | $0 | N/A | N/A |
| Free Cash Flow | -$39Kn/m | -$32Kn/m | N/A | N/A | -$20K | -$72K | N/A | N/A |
| Investing Cash Flow | -$50Kn/m | -$27Kn/m | $2Kn/m | $1K | $0 | $0 | $0 | N/A |
| Financing Cash Flow | $145K+616.9% | $33K-40.8% | $26K+17.1% | -$52K-1381.0% | $20K+168.2% | $56K+105.3% | $22K-82.4% | $4K+22.0% |
Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.
TRSO Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 93.0%-7.0pp | 90.0% | N/A | N/A | 100.0% | N/A | N/A | N/A |
| Operating Margin | N/A | N/A | N/A | -32114.0% | N/A | N/A | N/A | N/A |
| Net Margin | N/A | N/A | N/A | -32119.3% | N/A | N/A | N/A | N/A |
| Return on Equity | N/A | N/A | N/A | -146.9% | N/A | -3275.7% | N/A | N/A |
| Return on Assets | N/A | N/A | N/A | -55.8%+159.2pp | N/A | -151.0%-118.1pp | N/A | -215.0%-220.9pp |
| Current Ratio | 0.66-3.1x | 1.32-1.4x | 0.40+0.3x | 1.96+1.7x | 3.74+3.2x | 2.76+2.1x | 0.14-0.6x | 0.28+0.1x |
| Liabilities-to-Equity | N/A | 2.50-17.6x | N/A | 1.63 | 4.44 | 20.11 | N/A | N/A |
| Asset Turnover | 0.19+0.1x | 0.25+0.2x | N/A | 0.000.0x | 0.14+0.1x | 0.00 | N/A | 0.00-0.2x |
| FCF Margin | -31.3%+9.7pp | -26.3% | N/A | N/A | -41.0% | N/A | N/A | N/A |
Not reported in any period shown, so not listed: Debt-to-Equity.
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin.
Note: Shareholder equity is negative (-$485K), which causes the debt-to-equity, liabilities-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.40), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Transuite Org Inc TRSO | FY2025 | $118K | N/A | N/A | $15.5M | — |
| Avai Bio Inc AVAI | FY2026 | N/A | -$1.7M | N/A | $15.4M | — |
| Moatable Inc MTBLY | FY2024 | $63.5M | -$2.1M | -3.4% | $14.5M | — |
Where Transuite Org Inc Ranks
Frequently Asked Questions
Transuite Org Inc (TRSO) reported $118K in total revenue for fiscal year 2025. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
Transuite Org Inc (TRSO) had a gross margin of 99.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
Transuite Org Inc (TRSO) recorded an outflow of $69K in operating cash flow during fiscal year 2025, representing cash used by core business activities.
Transuite Org Inc (TRSO) had $337K in total assets as of fiscal year 2025, including both current and long-term assets.
Transuite Org Inc (TRSO) had a current ratio of 0.40 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
Transuite Org Inc (TRSO) has no price-to-earnings ratio at the moment: no net income reported. The market capitalization is $15.5M as of Oct 28, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
Transuite Org Inc (TRSO) trades at 131x sales, its market capitalization divided by $118K revenue, FY2025. The market capitalization is $15.5M as of Oct 28, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
At the end of fiscal year 2025, Transuite Org Inc (TRSO) held $4K in cash, cash equivalents and investments, and reported an operating cash outflow of $69K over that year. Dividing the one by the other, the reported balance equals about 1 month of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
Transuite Org Inc (TRSO) has negative shareholder equity of -$485K as of fiscal year 2025, so no debt-to-equity or liabilities-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.